HealthThe Recursiveabout 3 hours ago
Sensible Biotechnologies Secures €42M Funding
3 min read
Slovak-founded biotech startup Sensible Biotechnologies secured $47 million (€42 million) in financing to develop its cell-based mRNA platform. The round includes Series A funding led by Oxford Science Enterprises and up to $20 million in public support from the Slovak government and the European Union.
Level
Hype check
Tap to vote and see what everyone thinks.
